BioCision Receives $2,500,000 New Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b2c5c397-ae7d-4f4a-9d97-26460bfb3da9&Preview=1 - Date
12/6/2012 - Company Name
BioCision - Mailing Address
12 East Sir Francis Drake Blvd Larkspur, CA 94939 - Company Description
Our mission is to standardize pre-analytical sample handling. We develop and provide products that eliminate variability in common, often-overlooked, laboratory procedures. Our product lines are marketed globally through an extensive distributor network and have been readily adopted by the leading institutions in the biotech, pharmaceutical, clinical, diagnostic, academic and government scientific community. - Website
http://www.biocision.com - Transaction Type
Debt, Venture Equity - Transaction Amount
$2,500,000 - Transaction Round
Undisclosed - Proceeds Purposes
Funding will be used to support the company’s continued rapid growth and expansion of sales, marketing and product development efforts. - M&A Terms
- Venture Investor
BroadOak Capital Partners - Venture Investor
RCT BioVentures
